Performance of five non-instrumented urine drug-testing devices with challenging near-cutoff specimens

Journal of Analytical Toxicology

Volumn 25, Issue 8, 2001, Pages 670-679

  Kadehjian, L J ^a  

^a Biomedical Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG CONCENTRATION; DRUG SCREENING; GAS CHROMATOGRAPHY; INTERMETHOD COMPARISON; MASS SPECTROMETRY; URINALYSIS;

CASCO;

EID: 0035182863     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/25.8.670     Document Type: Article

References (48)

1. Emergency department evaluation of a rapid assay for detection of cocaine metabolites in urine specimens
2. Determination of tricyclic antidepressants for ED analysis
3. Evaluation of the Triage system for emergency drugs-of-abuse testing in urine
4. Rapid cocaine screening of urine in a newborn nursery
5. An evaluation of non-instrumented drug test devices for the division of workplace programs, center for substance abuse prevention, department of health and human services
6. Laboratory tests for rapid screening of drugs of abuse in the workplace: A review
7. Use of a visual panel detection method for drugs of abuse: Clinical and laboratory experience with children and adolescents
8. An evaluation of non-instrumented drug tests for the Administrative Office of the U.S, Courts, Duo Research, Inc.
9. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers
10. Testing reckless drivers for cocaine and marijuana
11. New rule proposed for home drug abuse test kits
12. Over-the-counter test system for drugs of abuse approved
13. Drug testing kit approved for sales in U.S.
14. Detecting cocaine and opiates in urine: Comparing three commercial assays
15. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices
16. Drugs-of-abuse testing in urine: Statistical approach and experimental comparison of immuno-chemical and chromatographic techniques
17. Clinical evaluation of the Triage analytical device for drugs-of-abuse testing
18. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: Effect of lowering the screening and GC-MS cut-off values
19. Application of the novel immunoassay TRIAGE to a rapid detection of antemortem drug abuse
20. Improved screening for benzodiazepine metabolites in urine using the Triage Panel for drugs of abuse
21. Detection of benzodiazepines and triazolams by Triage: Confirmation by solid-phase extraction utilizing SPEC·3ML·MP3 microcolumns and GC-MS
22. Simultaneous detection of seven drugs of abuse by Triage Panel for drugs of abuse
23. Validity testing of the AccuPinch THC test
24. Frontline immunochromatographic device for on-site urine testing of amphetamines: Laboratory validation using authentic specimens
25. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine
26. Validity testing of the EZ-SCREEN cannabinoid test
27. Evaluation of the EZ-SCREEN enzyme immunoassay test for detection of cocaine and marijuana metabolites in urine specimens
28. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results
29. ON-TRAK TESTCUP: A novel, onsite, multi-analyte screen for detection of abused drugs
30. Screening for drugs of abuse with the Roche ONTRAK assays
31. Evaluation of a rapid latex-particle agglutination-inhibition screening assay for cocaine in urine
32. Evaluation of bionike one-step tests for the detection of drugs of abuse in urine
33. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine
34. Evaluation of the Rapidrog cannabis noninstrumental immunoassay
35. Interference of gemfibrozil with Roche TesTcup
36. Accuracy of five on-site immunoassay drugs-of-abuse testing devices
37. Performance of Abusign drugs-of-abuse slide tests with particular emphasis on concentrations near the cut-off: Comparison with FPIA-ADx and confirmation of results with GC-MS
38. Potential for false-positive results by the Triage™ panel of drugs-of-abuse immunoassay
39. Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable
40. A preliminary evaluation of five rapid detection kits for on-site drugs of abuse screening
41. Validity testing of commercial urine cocaine metabolite assays: II. Sensitivity, specificity, accuracy, and confirmation by gas chromatography/mass spectrometry
42. Evaluation of InstaScreen cannabinoid drug screen test
43. An analysis of clinical toxicology urine specimens using the KDI Quik Test
44. Evaluation of the Keystone Diagnostic Quik Test
45. A discussion of the KDI Quik Test drug screen
46. Lack of validity of the KDI Quik Test drug screen for detection of benzoylecgonine in urine
47. Evaluation of the keystone Diagnostics Quik test using previously screened urine specimens
48. Distribution of the magnitude of Emit drug assay signals from emergency room patients